Metabolites associated with abnormal glucose metabolism responding to primary care lifestyle intervention
Type 2 diabetes can be prevented by lifestyle intervention. We aimed to identify metabolites that associate with glucose metabolism and respond to lifestyle intervention with evidence-based targets for nutrition and physical activity in individuals at high risk of type 2 diabetes. Standard oral glucose tolerance test (OGTT) was used to categorize 624 participants into those having normal glucose tolerance (NGT), isolated impaired glucose tolerance (IGT), IGT with increased fasting glucose (IGT + IFG), and type 2 diabetes. Plasma LC-MS metabolomics was performed to reveal metabolic signatures. The baseline group differences were analysed with the Kruskal-Wallis test and the effect of intervention with a linear mixed-effects model. Significant differences in the metabolite signature were observed between the baseline groups, particularly in amino acids, acylcarnitines, and phospholipids. Fatty acid amides, phospholipids, amino acids, dimethylguanidinovaleric acid, and 5-aminovaleric acid betaine responded most to the lifestyle intervention. Lysophosphatidylcholines containing odd-chain fatty acids showed associations with improved glucose metabolism. Twenty-five metabolites differed between the baseline groups, responded to the intervention, and were associated with changes in glucose metabolism. The findings suggest a metabolite panel could be used in distinguishing individuals with varying degrees of glucose metabolism and in predicting response to lifestyle interventions.
Authors
- Santtu Mikkonen (ORCID: https://orcid.org/0000-0003-0595-0657)
- Leila Karhunen (ORCID: https://orcid.org/0000-0001-5801-8041)
- Ursula Schwab
- Pilvikki Absetz (ORCID: https://orcid.org/0000-0002-1047-909X)
- Reija Männikkö (ORCID: https://orcid.org/0000-0002-1448-1971)
- Marjukka Kolehmainen (ORCID: https://orcid.org/0000-0002-3770-2538)
- Niina Lintu (ORCID: https://orcid.org/0000-0002-5456-1490)
- Timo A. Lakka (ORCID: https://orcid.org/0000-0002-9199-2871)
- Kaisa Poutanen (ORCID: https://orcid.org/0000-0002-2284-4162)
- Jussi Pihlajamäki (ORCID: https://orcid.org/0000-0002-6241-6859)
- Janne Martikainen (ORCID: https://orcid.org/0000-0003-0855-3921)
- Kati Hanhineva (ORCID: https://orcid.org/0000-0001-6834-7375)
- Kirsikka Aittola (ORCID: https://orcid.org/0000-0002-6283-7805)
- Ville Koistinen (ORCID: https://orcid.org/0000-0003-1587-8361)
- Jaana Lindström (ORCID: https://orcid.org/0000-0001-9255-020X)
- Marko Lehtonen (ORCID: https://orcid.org/0000-0002-5611-0466)
- Elina Järvelä‐Reijonen (ORCID: https://orcid.org/0000-0002-9346-3340)
- Suvi Manninen (ORCID: https://orcid.org/0000-0002-6548-4734)
- Tanja Tilles‐Tirkkonen (ORCID: https://orcid.org/0000-0002-8268-3401)
- Marjo Tuomainen
Institutions
- University of Turku (FI)
- Tampere University (FI)
- University of Eastern Finland (FI)
- Finnish Institute for Health and Welfare (FI)
- Kuopio University Hospital (FI)
- VTT Technical Research Centre of Finland (FI)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1038/s41598-025-25749-z
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Itä-Suomen Yliopisto
- Helsingin Yliopisto
- Kela
- Diabetesliitto
- Biocenter Finland
- Terveyden ja hyvinvoinnin laitos